Now showing items 6-15 of 1
Bevacizumab (1) |
bevacizumab (1) |
cancer chemotherapy (1) |
cancer combination chemotherapy (1) |
cancer staging (1) |
cetuximab (1) |
cost effectiveness analysis (1) |
cost utility analysis (1) |
Cost-effectiveness analysis (1) |
Cost-utility analysis (1) |
Now showing items 6-15 of 1